-
-
-
-
-
-
-
AcelRx Announces Date of FDA Advisory Committee Meeting for DSUVIA™
-
-
-
-
-
-
-
AcelRx Pharmaceuticals Reports First Quarter 2018 Financial Results
-
-
-
-
-
-
-
AcelRx Pharmaceuticals to Participate at Two Upcoming Investor Events in September
-
-
-
-
-
-
-
AcelRx Pharmaceuticals Appoints Raffi Asadorian as Chief Financial Officer
-
-
-
-
-
-
15,418 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

